Ro, which makes erectile dysfunction treatment, rolls out menopause meds

Ro, the company behind the D2C erectile dysfunction brand Roman, launched a new line of menopause meds under the name “Rory.”

Yesterday, the telehealth startup Ro launched a new product line called Rory for menopausal women.

Ro, which makes erectile dysfunction treatment, rolls out menopause meds

Rory, which will offer 6 separate products to treat 4 separate conditions, joins Ro’s other product lines Roman and Zero in a growing, convenience-focused telehealth business.

A series of priceless pivots

Ro started out in 2017 as a company called Roman, offering erectile dysfunction medication on demand.

Then, last September, the company raised $88m and launched a new line of products called Zero designed to help consumers quit smoking. At the launch of Zero, the company also changed its name to “Ro” — because, you know, cigs don’t discriminate. 

The name change seemed a little unnecessary at the time — but now that the company is going after menopausal women, it’s all starting to make sense.

The 2 different directions of Hims and Ro

Ro’s original service, Roman, competed directly with other direct-to-consumer ED products offered by companies like Hims. 

But while Hims chose to double down on its Him-ness with products designed specifically for men (hair-loss, skin care, oral care, etc.), Roman decided to do the opposite — and drop its man-focus.

Now, Ro prioritizes convenience over cohesion: The company uses the same business model — convenient, stigma-free on-demand delivery — to target 3 totally different demographic groups with telehealth products.

Get the 5-minute news brief keeping 2.5M+ innovators in the loop. Always free. 100% fresh. No bullsh*t.